EPO and anemia: Inflammation that we detected in mutant mice could be a driver of anemia in CKD, either directly through inhibition of EPO-mediated erythropoiesis or indirectly via disrupted iron regulation that limits hemoglobin synthesis in erythroid cells in the bone marrow [50].